Acmetel-MT 25 Tablet ER
Marketer
Acmedix Pharma LLP
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Acmetel-MT 25 Tablet ER
CardioPress ER 25mg tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. For consistent blood levels, take CardioPress ER 25mg with food daily, as directed by your physician. Continue treatment even if feeling well, as hypertension is often asymptomatic; premature discontinuation can worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, further aid blood pressure control. Strictly adhere to your doctor's instructions. Possible side effects include headache, weakness, dizziness, low blood pressure, elevated potassium, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be required. Inform your doctor of any liver or kidney issues before commencing treatment. Pregnant or breastfeeding individuals should consult their doctor before use. Disclose all medications, particularly those for hypertension or heart conditions.
Primary Ingredients of Acmetel-MT 25 Tablet ER
The provided text is "undefined," which lacks meaning and cannot be rephrased. A meaningful text is required for a paraphrase.
Uses of Acmetel-MT 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Acmetel-MT 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Acmetel-MT 25 Tablet ER whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.
Common Side effects of Acmetel-MT 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Acmetel-MT 25 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Acmetel-MT 25 Tablet ER whole; avoid chewing, crushing, or fracturing it. Take it with food.
How Acmetel-MT 25 Tablet ER works:
Acmetel-MT 25 Extended-Release tablets contain Telmisartan and Metoprolol Succinate, two agents that work together to reduce high blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Acmetel-MT 25 Tablet ER and alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Acmetel-MT 25mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingSAFE IF PRESCRIBED
The extended-release Acmetel-MT 25 Tablet likely poses minimal breastfeeding risk. Available human data indicates insignificant infant hazard.
DrivingUNSAFE
Extended-release Acmetel-MT 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Acmetel-MT 25 Extended-Release tablets are considered safe for use in individuals with renal impairment. No alteration of the Acmetel-MT 25 Extended-Release tablet dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should use Acmetel-MT 25 Tablet ER cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Acmetel-MT 25 Tablet ER :
Should you forget a dose of Acmetel-MT 25 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Acmetel-MT 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |



